Transcriptomics

#Drug discovery #High throughput screening #Omics #Transcriptomics

Company achieves breakthrough in transcriptomic drug discovery

QUANTRO Therapeutics has successfully completed its first 10-target multiplex-screening campaign, which yielded validated hits and functional proof of on-target activity for multiple molecular targets.   After establishing its technology for single- and dual-target screenings at a current capacity of approximately one million compounds per year, QUANTRO has… Read More

#News

#Alzheimer's #Collaboration #GSK #Muna Therapeutics #Neuroscience #Transcriptomics

GSK and Muna ally on novel treatments for Alzheimer’s disease

GSK and biotechnology company Muna Therapeutics have entered a research alliance to identify and validate novel drug targets for the treatment of Alzheimer’s disease.   The companies will explore insights from Muna’s MiND-MAP platform, which applies spatial transcriptomics to brain samples from Alzheimer’s disease patients, cognitively resilient individuals,… Read More

#Business & Investment #News

Drug discovery innovation
#AAV #Cell and gene therapy #Drug development #Drug discovery #Gene therapy #Genetics / genomics #Immunology / Virology & Vaccines #Interview #Life sciences #Market reporting #Precision medicine #RNA #RNA sequencing #Scandinavia #Sweden #Transcriptomics

Podcast: Innovation drivers and opportunities for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Innovation drivers and opportunities for drug discovery”, which covers three articles written Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Optimising AAV capsid purification through improved analytics How… Read More

#News

#Genomics #RNA biology #RNA Therapeutics #Serna Bio #Small molecules #Transcriptomics

The untapped potential of the transcriptome  

Serna Bio was founded by Rabia Khan, who is also the CEO, to unlock the transcriptome as a drug discovery target. DDW’s Megan Thomas speaks to Khan about the work her team is doing to create the first map of the druggable transcriptome, which involves understanding RNA biology to discover… Read More

#Exclusive Content #Opinion

#Epigenetics #Genomics #Multiomics #Nanopore sequencing #Omics #Proteomics #Transcriptomics

Multiomics sequencing: Find out what you’re missing

Download this new brochure ‘Multiomic nanopore sequencing solutions: Revolutionising human disease research‘ to maximise the data generated from your valuable research samples. Understanding the mechanisms of disease requires complex data ranging from genomic data through to transcriptomics, epigenetics and proteomics. Legacy multiomic approaches require multiple platforms… Read More

#News

#Epigenetics #Genomics #Multiomics #Nanopore sequencing #Omics #Proteomics #Transcriptomics

Multiomics sequencing: How to maximise the data generated from valuable research samples

Understanding the mechanisms of disease requires complex data ranging from genomic data through to transcriptomics, epigenetics and proteomics. Legacy multiomic approaches require multiple platforms and complex processes, which are incompatible with disease research that utilises scarce tissue samples. Download the brochure to learn how multiomic nanopore sequencing can… Read More

#Resources

Ageing hands
#Ageing #Artificial intelligence (AI) #Cancer research #Insilico Medicine #Transcriptomics #University of Chicago #University of Oslo

AI and transcriptomics identify dual targets for ageing and cancer

An international research team is the first to use artificial intelligence (AI) analysis to identify dual-purpose target candidates for the treatment of cancer and ageing. Researchers from the University of Oslo, University of Chicago Pritzker School of Medicine, and Insilico Medicine used Insilico’s AI target discovery… Read More

#Cancer Research #Editor's Choice #News

#Evotec #Genomics #High throughput screening #Metabolomics #Multi-omics #Proteomics #Transcriptomics

PanOmics: Advancing drug discovery

This article is sponsored by Evotec. To enable Evotec’s precision medicine approach, we have been building technology platforms that allow PanOmics or multi-omics data generation at an industrialised scale. The technologies cover the whole range of biomolecules from genes to protein to metabolites. While we are using… Read More

#News

Genomics
#Drug discovery #Gene editing #Genetics / genomics #Genome editing #The Jackson Laboratory #Transcriptomics

eBook: The impact of genomics on drug discovery

The latest eBook by DDW ‘The impact of genomics on drug discovery: Creating new opportunities’ is out now. This 24-page eBook sponsored by The Jackson Laboratory looks at the key use-cases for genomics and how it is improving drug discovery and development projects. Download this exclusive eBook to learn… Read More

#News

#Drug discovery #Gene editing #Genetics / genomics #Genome editing #The Jackson Laboratory #Transcriptomics

The impact of genomics on drug discovery: Creating new opportunities

This 24-page eBook sponsored by The Jackson Laboratory looks at the key use-cases for genomics and how it is improving drug discovery and development projects. Download this exclusive eBook to learn more about: If animal genomics can help find therapies for human disease Key challenges and drivers of the genomics market How… Read More

#DDW eBooks #Intelligence

T cells
#Antibodies #Cancer research #Immunotherapy #Oncology #T cell activation #Transcriptomics

Discovery could lead to more efficient cancer therapies

Scientists from Japan have identified regulator CD69, which controls the differentiation of CD8+ T cells within tumour-draining lymph nodes, thereby regulating anti-tumour immunity. Future cancer treatment based on antibodies against CD69 could enhance anti-tumour immune responses of CD8+ T cells and lead to more efficient cancer… Read More

#Cancer Research #News

Macrophage
#Cancer research #Immunology #Macomics #Mass spectrometry / NMR #Oncology #Transcriptomics #Tumour biology #Tumour microenvironment (TME)

Scottish company will target macrophages to treat cancer

Newly published discoveries have revealed possibilities for the treatment of cancer by targeting tumour-associated macrophages (TAMs) in the tumour microenvironment (TME).  The founding scientists behind Edinburgh-based Macomics, Dr Luca Cassetta and Professor Jeff Pollard, detail the seminal discoveries in macrophage biology over the past 50 years in… Read More

#Cancer Research #News

#Drug discovery #Genetics / genomics #Interview #Precision medicine #RNA #RNA sequencing #Transcriptomics

How transcriptomics is driving drug discovery

Listen to this article on the DDW Podcast: Dr Stephen Barat, Senior Vice President and Therapeutics Division Head at HTG Molecular Diagnostics tells DDW how transcriptomics is driving drug discovery and precision medicines. DDW: Could you explain the process of transcriptomics?  SB: Transcriptomics is the study… Read More

#Exclusive Content